Can a liver scan help diagnose heart failure in the ER?
Part of Heart & circulation clinical trials.
This study tests whether a quick, non-invasive liver scan (Fibroscan) can help diagnose heart failure in people who come to the emergency department with sudden shortness of breath.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are in the emergency room with new or sudden shortness of breath that has no clear cause (like a collapsed lung or pneumonia)
- You have health insurance (French Social Security), but not emergency medical aid (AME)
- You do not have known liver disease or liver scarring
- You do not have severe kidney disease (eGFR below 30)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at ways to better predict acute heart failure in people who come to the hospital with shortness of breath. If you join, researchers will use your information to develop a tool that might help doctors diagnose heart failure more quickly and accurately.
This trial tests a simple scoring tool to help doctors decide if patients with sudden heart failure can safely go home from the emergency department within 24 hours. It looks at vital signs and symptoms to see who is stable enough for discharge.
This study tests a new, non-invasive way to measure liver stiffness using a device called FibroScan. It aims to make liver checkups easier and more comfortable for people with liver disease.
This trial uses a special liver scan (FibroScan) to measure liver stiffness, which may help detect high pressure in the central veins returning blood to the heart. It is for people with heart failure who are already scheduled for a right heart catheterization.
This study is testing a new way to use a FibroScan (a non-invasive liver scanner) with a single probe to measure liver health in people with chronic liver disease. If you have a long-term liver condition, this trial may help improve how liver exams are done.
This study looks at whether a special EKG test (HF-QRS) and a blood test for fibrosis can help doctors better predict risks in people with chronic heart failure. If you join, you will help see if these tests work as well as or better than standard tests alone.
Hear when a new Acute Heart Failure (AHF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.